SCHEMBL6814524

SCHEMBL6814524

C#CC[C@H]1CC[C@H](CN)CC1

nearest known ligand 0.44

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
PLG P00747 1/20 0.44
PLAT P00750 1/20 0.44
LMNA P02545 1/20 0.44
NCF1 P14598 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6814518 1.00 PLG (0.44) PLGPLATLMNANCF1
SCHEMBL402037 0.86
SCHEMBL1703765 0.76 PLG (0.55) PLGPLATLMNANCF1
SCHEMBL6802 0.76
SCHEMBL432248 0.76 PLG (0.55) PLGPLATLMNANCF1
SCHEMBL48375 0.76 PLG (0.55) PLGPLATLMNANCF1
SCHEMBL235988 0.75
SCHEMBL6018785 0.75
SCHEMBL8792393 0.74 ALDH1A1 (0.32) LMNA
SCHEMBL927909 0.74 ESR1 (0.34)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1079860-B1 NICOTINE IMMUNOGEN INDEPENDENT PHARMACEUTICA AB (SE) 2004-10-27 EP disclosed
US-6656469-B1 Treatment of nicotine dependence from tobacco products INDEPENDENT PHARMACEUTICA AB (SE) 2003-12-02 US disclosed